Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
07/2014
07/08/2014CA2666682C Anti-il-13r.alpha.1 antibodies and their uses thereof
07/08/2014CA2638849C Antibodies that bind par-2
07/08/2014CA2628900C Monoclonal antibodies against .beta.3 integrins
07/08/2014CA2604933C Methods and compositions for modulating and detecting wisp activity
07/08/2014CA2599304C Cell targeting conjugates
07/08/2014CA2595800C Specific binding members for ngf
07/08/2014CA2595063C Emulsified composition for dilution and cancer vaccine composition
07/08/2014CA2564934C Recombinant lentiviral vector for expression of a flaviviridae protein and applications thereof as a vaccine
07/08/2014CA2559371C Influenza virus vaccines
07/08/2014CA2548792C Lsa-5 liver stage and blood stage antigen of plasmodium falciparum, immunogenic composition comprising said antigen, and vaccines against malaria
07/08/2014CA2547165C Mutated anti-cd22 antibodies and immunoconjugates
07/08/2014CA2536734C A rotavirus vaccine
07/08/2014CA2513711C Process for the preparation of hypoallergenic mosaic antigens
07/08/2014CA2493753C Immunostimulatory nucleic acids
07/08/2014CA2482705C Use of meglumine for inhibiting 3-deoxyglucosone synthesis in the skin
07/08/2014CA2482448C Preservation of bioactive materials by freeze dried foam
07/08/2014CA2480712C Chondrocyte therapeutic delivery system
07/08/2014CA2447593C Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
07/08/2014CA2417568C Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same
07/08/2014CA2395369C Cytokine zcyto18
07/03/2014WO2014106235A1 Anti-granulysin antibodies and methods of use thereof
07/03/2014WO2014106123A1 Signal peptide fusion partners facilitating listerial expression of antigenic sequences and methods of preparation and use thereof
07/03/2014WO2014106116A2 Delivery of biologic therapeutics
07/03/2014WO2014106104A1 Use of dr6 antagonists to improve motor neuron disease
07/03/2014WO2014105978A1 Methods of treatment using bevacizumab
07/03/2014WO2014105910A1 ANTI- INTEGRIN β1 ANTIBODY COMPOSITIONS AND METHODS OF USE THEREOF
07/03/2014WO2014105810A1 Prolactin receptor binding proteins and uses thereof
07/03/2014WO2014105672A1 Method of making a mycoplasma vaccine
07/03/2014WO2014105671A1 Immunogenic composition comprising mycoplasma antigens
07/03/2014WO2014104270A1 ANTIBODY RECOGNIZING FOLATE RECEPTORS α AND β
07/03/2014WO2014104165A1 Heterodimerized polypeptide
07/03/2014WO2014103608A1 Vaccine for hpv infection and/or hepatitis b containing hpv/hbs chimeric protein as active ingredient
07/03/2014WO2014103488A1 Nasal influenza vaccine composition
07/03/2014WO2014103310A1 Vaccine prepared utilizing human parainfluenza virus type 2 vector
07/03/2014WO2014102694A1 Novel mucinase for use in therapy or prophylaxis
07/03/2014WO2014102540A1 Vaccines against hepatitis b virus
07/03/2014WO2014102471A1 Monovalent and polyvalent vaccines against leishmania
07/03/2014WO2014102430A1 Therapeutic treatment of t- and b-acute lymphoblastic leukemia and human lymphomas by inhibition of the interleukin-7 receptor (il-7r)
07/03/2014WO2014102370A1 High temperature dead end antibody filtration
07/03/2014WO2014102299A2 Anti-lamp1 antibodies and antibody drug conjugates, and uses thereof
07/03/2014WO2014102220A1 Method for preparing an immunogenic lysate, the lysate obtained, dendritic cells loaded with such lysate and a pharmaceutical composition comprising the lysate or the dendritic cells
07/03/2014WO2014101903A1 Dengue virus vaccine composition
07/03/2014WO2014101210A1 Recombinant newcastle disease virus expressing protein h of peste des petits ruminants virus and applications of the virus
07/03/2014WO2014101195A1 Recombinant newcastle disease virus expressing protein f of peste des petits ruminants virus and applications of the virus
07/03/2014WO2014100857A1 Vaccines for the treatment of cancer and compositions for enhancing vaccine efficacy
07/03/2014WO2014100852A1 Inhibition of cancer growth and metastasis
07/03/2014WO2014074646A3 Induced intercellular communication
07/03/2014WO2014074528A3 Combination therapies using anti-pseudomonas psl and pcrv binding molecules
07/03/2014WO2014041088A3 Combined treatment with netrin-1 interfering drug and chemotherapeutic drug
07/03/2014WO2013192240A3 Compositions and methods of inhibiting masp-1 and/or masp-2 and/or masp-3 for the treatment of various diseases and disorders
07/03/2014WO2013082327A8 Recombinant hvt vectors expressing antigens of avian pathogens and uses thereof
07/03/2014US20140186917 Compositions for Diagnosis and Therapy of Diseases Associated with Aberrant Expression of Futrins (R-Spondins) and/or Wnt
07/03/2014US20140186887 RECEPTOR ACTIVATOR OF NF-kappaB
07/03/2014US20140186860 Novel immunogenic proteins of leptospira
07/03/2014US20140186404 Methods for treating multiple myeloma using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione in combination with antibodies
07/03/2014US20140186403 Peptide for vaccine
07/03/2014US20140186402 Blood Stage Malaria Vaccine
07/03/2014US20140186400 Methods and compositions for treating autoimmune diseases
07/03/2014US20140186399 Protein matrix vaccines and methods of making and administering such vaccines
07/03/2014US20140186398 BACTERIAL RNAs AS VACCINE ADJUVANTS
07/03/2014US20140186396 Methods for stabilizing influenza antigen enveloped virus-based virus-like particle solutions
07/03/2014US20140186394 Method of making a mycoplasma vaccine
07/03/2014US20140186393 Immunogenic composition comprising mycoplasma antigens
07/03/2014US20140186392 Interferon-ß Production Modulating Listeria Strains and Methods for Using Same
07/03/2014US20140186391 Vaccine against rsv
07/03/2014US20140186386 Methods for preventing and treating staphylococcus aureus colonization, infection, and disease
07/03/2014US20140186385 Potomac horse fever isolates
07/03/2014US20140186384 Vaccines and methods for using the same
07/03/2014US20140186382 Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection
07/03/2014US20140186381 Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides
07/03/2014US20140186379 Novel macromolecule transduction domains and methods for identification and uses thereof
07/03/2014US20140186378 Glycolipids and analogues thereof as antigens for nkt cells
07/03/2014US20140186377 Prostaglandin e2 binding proteins and uses thereof
07/03/2014US20140186375 Combination of Immuno Gene Therapy and Chemotherapy for Treatment of Cancer and Hyperproliferative Diseases
07/03/2014US20140186374 Manipulation of regulatory t cell and dc function by targeting neuritin gene using antibodies, agonists and antagonists
07/03/2014US20140186371 Compositions and methods for treating diseases of protein aggregation involving ic3b deposition
07/03/2014US20140186368 METHODS OF ADMINISTERING ANTI-TNFalpha ANTIBODIES
07/03/2014US20140186367 Methods and compositions related to glucocorticoid receptor antagonists and breast cancer
07/03/2014US20140186362 Anti-Interferon Gamma Antibodies And Methods Of Use Thereof
07/03/2014US20140186360 Phosphorylcholine conjugates and corresponding antibodies
07/03/2014US20140186359 Pharmaceutical composition for treatment and/or prophylaxis of cancer
07/03/2014US20140186357 Method for treatment of degenerative brain disorders comprising inhibitor of sum01 and bace1 interaction as an active ingredient
07/03/2014US20140186356 Combination of a c-met antagonist and an aminoheteroaryl compound for the treatment of cancer
07/03/2014US20140186350 Compositions and methods for long acting molecules
07/03/2014US20140186349 Human cdr-grafted antibody and antibody fragment thereof
07/03/2014US20140186347 Extending time to disease progression or survival in cancer patients
07/03/2014US20140186345 Method of administering an antibody
07/03/2014US20140186344 Roles for dual endothelin-1/angiotensin ii receptor (dear) in hypertension and angiogenesis
07/03/2014US20140186342 Compositions and Methods for Diagnosing and Treating Cancer
07/03/2014US20140186341 Methods for improving drug efficacy
07/03/2014US20140186337 Antitumors Combinations Containing Antibodies Recognizing Specifically CD38 And Bortezomib
07/03/2014US20140186336 Methods of treating pterygium
07/03/2014US20140186298 T-Cell Vaccination With Viral Vectors Via Mechanical Epidermal Disruption
07/03/2014US20140186296 Methods for Treatment of HIV and Other Infections Using a T-Cell or Viral Activator and Anti-Retroviral Combination Therapy
07/03/2014US20140186295 Methods and compositions for the treatment of cancer
07/03/2014US20140186292 Defective ribosomal products in blebs (dribbles) and methods of use to stimulate an immune response
07/03/2014CA2862067A1 Pharmaceutical composition of recombinant polyclonal immunoglobulins
07/02/2014EP2749641A1 Cancer stem cell isolation
07/02/2014EP2749639A1 Proliferating agent for monocyte, culture medium for proliferating monocyte, method for producing monocyte, method for producing dendritic cell, and method for producing dendritic cell vaccine
07/02/2014EP2749573A1 Agr2 blocking antibody and use thereof
1 ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 ... 1823